Biosimilars Litigation and Client Counseling
April 24, 2025
By: Aziz Burgy, Ricardo Camposanto, Darpan R. Singh
American Bar Association Section of Intellectual Property Law
Axinn partner Aziz Burgy and associates Ricardo Camposanto and Darpan Singh co-authored a chapter in the ABA Section of Intellectual Property Law publication, Biosimilars Litigation and Client Counseling.
Biosimilars Litigation and Client Counseling is a guide to the field of biologic products and biosimilars, as well as the laws governing them, most notably the Biologics Price Competition and Innovation Act.
Click here to access the publication.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Partner Rebecca Clegg Named to Hartford Business Journal’s 2026 40 Under Forty
Awards & Recognitions
What Happens in Vegas Stays in Vegas: Third Circuit Parts Ways with Ninth Circuit and Reinstates Atlantic City Algorithmic-Pricing Claim
Axinn Viewpoints
Antitrust
What Should Directors Be Asking? Antitrust in the Boardroom
Podcast
Antitrust
Axinn Represents Modular in $4 Billion Acquisition by Qualcomm
Deals & Cases
Antitrust
Will New DOJ Timing Agreement Deliver Faster Merger Clearances?
Axinn Viewpoints
Antitrust
Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
Byline Articles
Antitrust
Women Leaders in Life Sciences Law
Speaking Engagement
Litigation & Trials
American Bar Association: Inside Antitrust Enforcement—Former Government Perspectives
Webinar
Antitrust